Data as of Apr 17
| -0.05 / -3.03%|
There is no forecast data available.
The current consensus among 1 polled investment analysts is to Buy stock in Pharma-Bio Serv Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.